You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

macular

Showing 26 - 50 of 4,701
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Mesa, Phoenix (Faricimab PFS Configuration)

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Faricimab PFS Configuration
  • Mesa, Arizona
  • +2 more
Jan 2, 2023

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])

Not yet recruiting
  • Age-related Wet Macular Degeneration
  • CG-P5 peptide
  • +2 more
  • Augusta, Georgia
  • +3 more
Nov 13, 2023

Artificial Intelligence Diagnostic Aid

Not yet recruiting
  • Wet Macular Degeneration
  • +2 more
  • Macusense Assessment Software
  • London, Westminster, United Kingdom
    Guy's and St Thomas's NHS Foundation Trust
Dec 29, 2022

Intestinal Microbiome in Wet Age-related Macular Degeneration

Recruiting
  • Age-Related Macular Degeneration
  • Sample examination
  • Ioánnina, Epirus, Greece
  • +1 more
Feb 23, 2023

Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

Not yet recruiting
  • Age-Related Macular Degeneration
  • NG101 AAV gene therapy
  • Toronto, Ontario, Canada
    Vitreous Retina Macula Specialists of Toronto
Aug 2, 2023

Age Related Macular Degeneration Trial in Bern (NUTROF TOTAL)

Completed
  • Age Related Macular Degeneration
  • NUTROF TOTAL
  • Bern, Switzerland
    Department of Ophthalmology, Inselspital, Bern University Hostpi
Jan 24, 2023

Diabetic Macular Edema Trial in Beijing (ASKG712)

Not yet recruiting
  • Diabetic Macular Edema
  • ASKG712
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Jul 12, 2023

Neovascular Age-related Macular Degeneration Trial (AXT107 Low Dose, AXT107 Mid Dose, AXT107 High Dose)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • AXT107 Low Dose
  • +2 more
  • (no location specified)
May 5, 2023

Diabetic Macular Edema Trial in Tianjin (FT-003)

Recruiting
  • Diabetic Macular Edema
  • FT-003
  • Tianjin, Tianjin,China, China
    Tianjin Medical University Eye Hospital
Jun 14, 2023

Rehabilitating Vision Loss in Veterans With Age-Related Macular

Not yet recruiting
  • Age-related Macular Degeneration (AMD)
  • Study-specific rehabilitation (SSR) procedures
  • Augusta, Georgia
    Charlie Norwood VA Medical Center, Augusta, GA
Mar 10, 2023

Progression of Early Atrophic Lesions

Not yet recruiting
  • Age-Related Macular Degeneration
  • No intervention
  • Salt Lake City, Utah
    University of Utah
Jul 26, 2023

Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy Trial in Rome (subthreshold treatment with micropulsed laser)

Not yet recruiting
  • Macular Edema
  • +2 more
  • subthreshold treatment with micropulsed laser
  • Rome, RM, Italy
    IRCSS Fondazione G:B:Bietti
Jul 27, 2023

Center Involved Diabetic Macular Edema, Diabetic Macular Edema Trial (OCU200 Low Dose, OCU200 Medium Dose, OCU200 High Dose)

Not yet recruiting
  • Center Involved Diabetic Macular Edema
  • Diabetic Macular Edema
  • OCU200 Low Dose
  • +2 more
  • (no location specified)
Mar 27, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • OCU-10-C-110 for Injection
  • Abilene, Texas
    Retina Research Institute of Texas
Jun 6, 2023

Diabetic Macular Edema Trial in Mexico city (Intravitreal dexamethasone implant)

Completed
  • Diabetic Macular Edema
  • Intravitreal dexamethasone implant
  • Mexico city, Coyoacan, Mexico
    Asociacion Para Evitar la Ceguera en Mexico
Feb 20, 2023

Age-Related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial (Active microcurrent therapy)

Completed
  • Age-Related Macular Degeneration
  • Nonexudative Age-related Macular Degeneration
  • Active microcurrent therapy
  • (no location specified)
Jan 28, 2023

Macular Holes Trial in Shanghai (Translocation ILM Flap, ILM Peeling)

Recruiting
  • Macular Holes
  • Translocation ILM Flap
  • ILM Peeling
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiao Tong University Scho
Sep 25, 2023

Age-Related Macular Degeneration Trial in Worldwide (Yellow and red light emitting diode photobiomodulation (Eye Light,

Recruiting
  • Age-Related Macular Degeneration
  • Yellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)
  • Sham Mask
  • Paris, France
  • +6 more
Sep 14, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • AR-14034 SR implant lower dose
  • +3 more
  • (no location specified)
Mar 3, 2023

Describing DME, Their Patient Journey and Disease Progression

Not yet recruiting
  • Diabetic Macular Edema
    • (no location specified)
    Jul 21, 2023

    Aflibercept for Diabetic Macular Edema In Real-life Practice in

    Completed
    • Diabetic Macular Edema
    • Athens, Greece
      University of Athens
    Dec 27, 2022

    Neovascular Age-related Macular Degeneration Trial in Shanghai (LX102-C01 Injection)

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • LX102-C01 Injection
    • Shanghai, China
      Shanghai General Hospital, Shanghai Jiao Tong University School
    Apr 14, 2023

    Uveitic Macular Edema Trial in Istanbul (RO7200220, Sham)

    Not yet recruiting
    • Uveitic Macular Edema
    • Istanbul, Turkey
      Istanbul University Cerrahpasa Faculty of Medicine
    Jan 6, 2023

    Diabetic Macular Edema Trial (K8)

    Not yet recruiting
    • Diabetic Macular Edema
    • (no location specified)
    Jan 27, 2023